<VariationArchive RecordType="classified" VariationID="988223" VariationName="NM_030787.3:c.(58+1_59-1)_(430+1_431-1)dup" VariationType="Duplication" Accession="VCV000988223" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-26" DateCreated="2021-03-22" MostRecentSubmission="2021-03-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="976036" VariationID="988223">
      <GeneList>
        <Gene Symbol="CFHR5" FullName="complement factor H related 5" GeneID="81494" HGNC_ID="HGNC:24668" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="196975034" stop="197009678" display_start="196975034" display_stop="197009678" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_025791754.1" start="740149" stop="774808" display_start="740149" display_stop="774808" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="196946666" stop="196978803" display_start="196946666" display_stop="196978803" Strand="+" />
          </Location>
          <OMIM>608593</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_030787.3:c.(58+1_59-1)_(430+1_431-1)dup</Name>
      <VariantType>Duplication</VariantType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_227t1" sequenceAccession="LRG_227t1">
            <Expression>LRG_227t1:c.(58+1_59-1)_(430+1_431-1)dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_030787.3:c.(58+1_59-1)_(430+1_431-1)dup AND Atypical hemolytic-uremic syndrome" Accession="RCV001328250" Version="1">
        <ClassifiedConditionList TraitSetID="7947">
          <ClassifiedCondition DB="MedGen" ID="C2931788">Atypical hemolytic-uremic syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-08-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-08-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-03-22" MostRecentSubmission="2021-03-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7947" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9459" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Atypical hemolytic-uremic syndrome</ElementValue>
                <XRef ID="MONDO:0016244" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Atypical HUS</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AHUS</ElementValue>
                <XRef ID="GTR000515140" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">D-HUS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hemolytic-uremic syndrome (HUS) is characterized by hemolytic anemia, thrombocytopenia, and renal failure caused by platelet thrombi in the microcirculation of the kidney and other organs. The onset of atypical HUS (aHUS) ranges from the neonatal period to adulthood. Genetic aHUS accounts for an estimated 60% of all aHUS. Individuals with genetic aHUS frequently experience relapse even after complete recovery following the presenting episode; 60% of genetic aHUS progresses to end-stage renal disease (ESRD).</Attribute>
                <XRef ID="NBK1367" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301541</ID>
                <ID Source="BookShelf">NBK1367</ID>
              </Citation>
              <Citation Type="review" Abbrev="NEJM, 2009">
                <ID Source="PubMed">19846853</ID>
              </Citation>
              <Citation Type="general" Abbrev="Brit Cmt Stand Hematol/BTS, 2010">
                <ID Source="PubMed">19821824</ID>
              </Citation>
              <XRef ID="2134" DB="Orphanet" />
              <XRef ID="C2931788" DB="MedGen" />
              <XRef ID="MONDO:0016244" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2862300" SubmissionDate="2020-09-18" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="CHW_MG_F308P1|MONDO:16244" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001449228" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Sydney Genome Diagnostics, Children's Hospital Westmead" OrgID="507757" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-08-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This patient is heterozygous for a duplication of exons 2 and 3 of the CFHR5 gene. This variant has been reported in the literature as the causative mutation of C3 glomerulonephritis in patients of Cypriot origin (Gale et al 2010 Lancet 376:794-801; Athanasiou et al 2011 Clin J Am Soc Nephrol 6:1436-1446). The duplication of exons 2 and 3 was shown to be within the CFHR5 gene and affected the affinity of complement binding in vitro. The physiological impact of this is uncertain (Gale et al 2010). This variant is considered to be likely pathogenic according to the ACMG guidelines.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFHR5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030787.3:c.(58+1_59-1)_(430+1_431-1)dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0016244" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8161327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2862300" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0016244" MappingRef="MONDO">
        <MedGen CUI="C2931788" Name="Atypical hemolytic-uremic syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

